John Kuch is the CEO of Xencor, a biotech company known for its innovative treatments. He holds an MBA and has a strong background in finance, gained from over 15 years in public accounting and significant experience with prominent firms...

John Kuch is the CEO of Xencor, a biotech company known for its innovative treatments. He holds an MBA and has a strong background in finance, gained from over 15 years in public accounting and significant experience with prominent firms like PricewaterhouseCoopers. In 2023, he revealed his plans to retire after more than 14 years with Xencor, marking a significant transition for the company. Under his leadership, Xencor not only achieved corporate performance goals but also attracted substantial investments, including a groundbreaking partnership with Genentech that significantly boosted the company's market position. Throughout his career, Kuch has balanced his responsibilities with a focus on expanding Xencor's financial strategies, while earning consistent performance bonuses. At one point, his insider holdings peaked at over $4.12 million, reflecting his deep investment in the company’s success. Kuch's journey demonstrates a commitment to innovation and success in the biotech industry, leaving behind a legacy of growth and strategic partnerships.

Quick Links

1. Rivals

2. Holdings

3. Insider Trading

4. Compensation History

5. Other Xencor CEOs

X

John Kuch

Ex-CEO of Xencor

Education

MBA from a recognized business school

Field of Expertise

Finance & Banking - Finance

Sector of Economy

Healthcare

Born

May 1, 1958 - 67 years ago

CEO of Xencor for

8 years 2 months (Jan 2016 - Apr 2024)

Previous Experience

CFO at various biotech companies

Rivals

Competitors/colleagues of John Kuch

Holdings

See how much did John Kuch make over time.

John Kuch's holdings in Xencor peaked at impressive values over his tenure. In early 2021, his insider holdings reached about $4.12 million but have since fluctuated with the company's performance. As he prepares for retirement in 2024, his current holdings...

John Kuch's holdings in Xencor peaked at impressive values over his tenure. In early 2021, his insider holdings reached about $4.12 million but have since fluctuated with the company's performance. As he prepares for retirement in 2024, his current holdings are around $2.30 million, showcasing his substantial investment in the company he helped grow. Over the years, he has seen significant value from his shares, particularly in early 2021 when the company's stock was buoyed by successful strategic moves. This trajectory reflects his alignment with Xencor's long-term vision and financial health.

Mar 11, 2025

X

shares

XNCR @ $13.53

Total Stock Sold

$4.90M

XNCR

$4.90M

145,795 XNCR shares

What if they kept their stock?

If John Kuch didn't sell their stock, today they would have:
Extra XNCR145,795 shares worth $4.26M.
This is -13.04% and $639.03K less than what they got when they sold the stock.

Charitable Transactions

XNCR

18,500 shares

XNCR

Recent Charitable Transactions

XNCR

7,000 shares

XNCR

Dec 31, 2022

Charity

XNCR

6,500 shares

XNCR

Dec 31, 2021

Charity

XNCR

2,500 shares

XNCR

Dec 11, 2020

Charity

XNCR

2,000 shares

XNCR

Jun 12, 2020

Charity

XNCR

500 shares

XNCR

Dec 12, 2019

Charity

Insider Trading

See recent insider trades of John Kuch.

XNCR

$19.95K

XNCR at $23.50/share

Mar 11, 2024

Sale

XNCR

$104.82K

XNCR at $23.43/share

Mar 5, 2024

Sale

XNCR

$21.24K

XNCR at $29.88/share

Mar 9, 2023

Sale

XNCR

$87.15K

XNCR at $31.42/share

Mar 6, 2023

Sale

XNCR

$28.98K

XNCR at $31.54/share

Mar 2, 2023

Sale

XNCR

12,005 shares

XNCR

Mar 2, 2023

Received

XNCR

7,000 shares

XNCR

Dec 31, 2022

Charity

XNCR

7,000 shares

XNCR

Dec 31, 2022

Charity

XNCR

$19.96K

XNCR at $28.93/share

Mar 9, 2022

Sale

XNCR

$28.99K

XNCR at $29.86/share

Mar 3, 2022

Sale

Compensation History

See how much did John Kuch make over time.

John Kuch's compensation plan emphasizes performance-based rewards tied directly to Xencor’s success. In 2023, he earned a total of $679,247, which included a salary of $468,000 and a performance bonus of $179,000, reflecting his valuable contributions. The bonus system rewards him for meeting corporate goals, and in 2022, he achieved a performance goal award of 150%. His stock options and various executive benefits further enhance his earnings, revealing a successful strategy that marries compensation with the company’s financial growth. This approach ensures that his interests align with those of shareholders, driving progress within Xencor's mission.

Year

2023

Total Compensation

$1.06M

Salary

$468.00K

Board Justification

The compensation philosophy emphasizes performance-based pay, aligning executive compensation with company performance and shareholder interests.

Bonus

$179.00K

Board Justification

The annual performance-based bonus was calculated based on the target bonus percentage of 45% of base salary and the achievement of corporate goals at 85% for the year 2023.

Other

$9.25K

Board Justification

This includes term life and disability insurance premiums paid by the company on behalf of the CEO, as well as matching contributions made under the 401(k) plan.

Restricted Stock

$400.00K(12.01K RSU)

Board Justification

The RSUs granted in 2023 vested in equal installments over three years, with the first third vesting on the first anniversary of the grant date.

Performance Metrics

The performance metrics for the CEO's compensation are based on the achievement of corporate goals set by the Board, with a specific focus on financial and operational performance.

Other Xencor CEOs

Here are other CEOs of Xencor

A. Bruce Montgomery, M.D.

Ex-CEO of Xencor

March 2015 - January 2016

Bart Cornelissen

CEO of Xencor

April 2024 - Present